Sienna-Clarity COVID-19 Antigen Rapid Test Kits, Includes: (25) Tests, (25) NP Swabs, (25) Buffers, Package Insert, QSG, (1) Negative Control, and (1) Positive Control/kt (Orders are Non-Cancellable; Item is Non-Returnable)
- Relative Sensitivity: 87.5%
- Relative Specificity: >98.9%
Price Per Box or Kit
|1-9 Boxes 25 Test Kits per Box||$250 ($10 per Test)|
|10 - 587 Boxes||$200 ($8 per Test)|
|Pallet = 588 Boxes||Call for Pricing|
|*Bulk Pricing Reflected in Cart|
Pallet Pricing on 588 Boxes or 14,700 Tests, Please Call 1-877-945-2876 for Quote. Lowest Prices Guaranteed on Large Quantities.
- Printable PDF Flyer
- FDA EUA
- Package Insert
- Fact Sheet for Healthcare Providers
- Fact Sheet for Recipients
- MDS SDS CLA-COV19AF-VIS
- Test Performance against Variants
Clarity COVID-19 Rapid Antigen Test is a quick and easy test providing rapid results in as fast as 5 minutes. The test is FDA Emergency Use Authorized, CLIA Waived and POCT approved. It has a relative sensitivity of 87.5% and a relative specificity of >98.9%.
The Clarity COVID-19 Antigen test can be used to test with directly collected naso-pharyngeal swab specimens. The Clarity COVID-19 Antigen test should be ordered for the detection of COVID-19 antigen in individuals who are suspected of COVID-19 by their healthcare provider and who are within six days of symptom onset.
The Clarity COVID-19 Rapid Antigen Test is a type of antigen test designed to detect proteins from the virus that causes COVID-19 in nasopharyngeal swabs. The presence of viral proteins indicate you may have been infected with the virus and are likely to be contagious. If you have a positive test result, it is highly likely that you have contracted COVID-19 because of the presence of proteins from the virus were discovered in your sample.
Due to FDA Guidelines and Supply Chain Demands All Orders for this Product are NON-Cancellable and NON-Returnable.
By purchasing the Clarity Antigen Test from Wilburn Medical you agree to the following guidelines:
This test has not been FDA cleared or approved; the test has been authorized by FDA under an Emergency Use Authorization (EUA) for use by laboratories certified under the CLIA that meet the requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC) by qualified healthcare professionals, i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
Call for Pallet Pricing